ID

12812

Descrição

Retrospective Analysis of Survival in Adult MRD Positive Acute Lymphoblastic Leukemia Patients; ODM derived from: https://clinicaltrials.gov/show/NCT02010931

Link

https://clinicaltrials.gov/show/NCT02010931

Palavras-chave

  1. 21/12/2015 21/12/2015 -
Transferido a

21 de dezembro de 2015

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0

Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Comentários do grupo de itens para :

Comentários do item para :


Sem comentários

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Acute Lymphoblastic Leukemia NCT02010931

Eligibility Acute Lymphoblastic Leukemia NCT02010931

Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with philadelphia-negative b-precursor acute lyphmoblastic leukemia in complete hematological remission defined as less than 5 percent blasts in bone marrow after at least 3 intensive chemotherapy blocks (i.e. any standard or investigational regimen according to adult protocols as long as 3 age appropriate chemotherapy blocks were given, this also includes relapse treatment
Descrição

philadelphia-negative b-precursor acute lyphmoblastic leukemia in complete hematological remission

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1960645
UMLS CUI [2]
C0457341
detection of minimal residual disease (molecular failure or molecular relapse) at a level of greater than or equal to 10*(-4) by pcr or greater than or equal to 10*(-3) by flow cytometry at a reference lab
Descrição

detection of minimal residual disease

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1511791
age 15 or greater at time of initial diagnosis with acute lymphoblastic leukemia. for patients aged 15-17 treatment according to adult protocols is required
Descrição

age

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0001779
initial diagnosis in the year 2000 or later
Descrição

initial diagnosis

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0011900
UMLS CUI [2]
C0332168
history of acute lymphoblastic leukemia treatment (including response to first therapy, number of prior relapses) is available
Descrição

patient medical history

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0262926
relapse status and disease follow up after timepoint of minimal residual disease detection is available
Descrição

relapse status and disease follow up

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1277192
UMLS CUI [2]
C0589120
Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with extramedullary disease at timepoint of minimal residual disease detection
Descrição

extramedullary disease

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1868812
use of blinatumomab within 18 months of minimal residual disease detection
Descrição

blinatumomab

Tipo de dados

boolean

Alias
UMLS CUI [1]
C3853839
allogeneic hematopoietic stem cell transplantation prior to minimal residual disease detection at the required level
Descrição

allogeneic hematopoietic stem cell transplantation

Tipo de dados

boolean

Alias
UMLS CUI [1]
C2242529

Similar models

Eligibility Acute Lymphoblastic Leukemia NCT02010931

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
philadelphia-negative b-precursor acute lyphmoblastic leukemia in complete hematological remission
Item
patients with philadelphia-negative b-precursor acute lyphmoblastic leukemia in complete hematological remission defined as less than 5 percent blasts in bone marrow after at least 3 intensive chemotherapy blocks (i.e. any standard or investigational regimen according to adult protocols as long as 3 age appropriate chemotherapy blocks were given, this also includes relapse treatment
boolean
C1960645 (UMLS CUI [1])
C0457341 (UMLS CUI [2])
detection of minimal residual disease
Item
detection of minimal residual disease (molecular failure or molecular relapse) at a level of greater than or equal to 10*(-4) by pcr or greater than or equal to 10*(-3) by flow cytometry at a reference lab
boolean
C1511791 (UMLS CUI [1])
age
Item
age 15 or greater at time of initial diagnosis with acute lymphoblastic leukemia. for patients aged 15-17 treatment according to adult protocols is required
boolean
C0001779 (UMLS CUI [1])
initial diagnosis
Item
initial diagnosis in the year 2000 or later
boolean
C0011900 (UMLS CUI [1])
C0332168 (UMLS CUI [2])
patient medical history
Item
history of acute lymphoblastic leukemia treatment (including response to first therapy, number of prior relapses) is available
boolean
C0262926 (UMLS CUI [1])
relapse status and disease follow up
Item
relapse status and disease follow up after timepoint of minimal residual disease detection is available
boolean
C1277192 (UMLS CUI [1])
C0589120 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
extramedullary disease
Item
patients with extramedullary disease at timepoint of minimal residual disease detection
boolean
C1868812 (UMLS CUI [1])
blinatumomab
Item
use of blinatumomab within 18 months of minimal residual disease detection
boolean
C3853839 (UMLS CUI [1])
allogeneic hematopoietic stem cell transplantation
Item
allogeneic hematopoietic stem cell transplantation prior to minimal residual disease detection at the required level
boolean
C2242529 (UMLS CUI [1])

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial